Thyroid Cancer Trial, Recruiting (NCT03517579)

Thyroid Cancer Trial, Recruiting NCT03517579 Sponsor: Johns Hopkins University Condition: Thyroid Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT03517579 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Thyroid Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Graves' disease (an overactive thyroid condition) that has been confirmed by blood tests (Group I).
You are able to understand English and follow instructions (Group I).
You have been diagnosed with differentiated thyroid cancer that is considered intermediate or high risk, and your doctor has recommended radioiodine (a radioactive iodine treatment) to treat remaining thyroid tissue or disease in the neck area (Group II).
You are able to understand simple English and follow instructions (Group II).

Who may not be able to join:

You have a condition affecting the bones or joints in your neck, such as spondylosis (wear and tear of the spine) or severe joint disease in that area.
You are currently pregnant.
You are elderly (confirm with trial site for the specific age threshold).
You are unable to understand or follow simple instructions.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Prasanna Santhanam, MBBS, MD, Johns Hopkins University

Phone: 410-550-6023

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03517579

Sponsor: Johns Hopkins University

Phase: Not Applicable

Status: Recruiting

Condition: Thyroid Cancer

Trial contact: 410-550-6023

More information: https://clinicaltrials.gov/study/NCT03517579

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Graves' disease (an overactive thyroid condition) that has been confirmed by blood tests (Group I).
You are able to understand English and follow instructions (Group I).
You have been diagnosed with differentiated thyroid cancer that is considered intermediate or high risk, and your doctor has recommended radioiodine (a radioactive iodine treatment) to treat remaining thyroid tissue or disease in the neck area (Group II).
You are able to understand simple English and follow instructions (Group II).

Who may not be able to join:

You have a condition affecting the bones or joints in your neck, such as spondylosis (wear and tear of the spine) or severe joint disease in that area.
You are currently pregnant.
You are elderly (confirm with trial site for the specific age threshold).
You are unable to understand or follow simple instructions.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Johns Hopkins University

Registry

ClinicalTrials.gov

Start date

11 December 2018

Est. completion

15 October 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Evaluation of the Variability in radioiodine kinetics for patients with thyroid cancer and graves disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov